Nilsine Partners, LLC Novartis Ag Transaction History
Nilsine Partners, LLC
- $745 Billion
- Q2 2024
A detailed history of Nilsine Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Nilsine Partners, LLC holds 5,789 shares of NVS stock, worth $663,129. This represents 0.08% of its overall portfolio holdings.
Number of Shares
5,789
Previous 5,679
1.94%
Holding current value
$663,129
Previous $549 Million
12.19%
% of portfolio
0.08%
Previous 0.08%
Shares
6 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.4 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.4 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$850 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$849 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$681 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $246B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...